atarabio.com (ATRA) Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization
Atara Biotherapeutics is minimizing risks by creating affordable cell therapy for the mass treatment of autoimmune pathologies and oncology. Processes are being optimized through the implementation of robotic analysis systems and predictive software. This technological priority in biotech grants the Ebvallo platform innovator status in immunotherapy. The market capitalization trend based on the EV/EBITDA metric stands at 0.00, as shown in this chart.
atarabio.com - analytical breakdowns and key metrics (ATRA)
- current price and projected stock value:
- market capitalization details:
- book value of equity indicators:
- debt level and financial liquidity data:
- business earnings and investment ratios data:
ATRA - Net Profit|Expected Profit Atara Biotherapeutics|ATRA - Company Value to Net Income|Forward P/E Multiple Atara Bio|ATRA - PEG Multiple|Enterprise Value to EBITDA Ratio ATRA|ATRA - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Atara Biotherapeutics|ATRA - Earnings per share for the last twelve months|Quarterly EPS earnings growth atarabio.com|ATRA - Expected net earnings per share growth this year|Net earnings per share growth forecast for next year Atara Biotherapeutics
Initial company analysis:Atara Biotherapeutics Inc ATRA
The modernization of cell therapy production at Atara Biotherapeutics (ATRA) requires significant capital expenditures, making the analysis of the enterprise value to EBITDA ratio critical for assessing the debt load. This chart of the company's EV/EBITDA dynamics reflects its ability to generate cash flow to service obligations, where a sharp increase in the multiple indicates asset overheating and risks of investment impairment.
Competitors of Atara Biotherapeutics
EV/EBITDA Multiple ARGX (Argenx)|Total Company Value to Operating Income Before Depreciation Ratio BioNTech Pharma (BNTX)|ABVX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|admabiologics.com (ADMA) - Enterprise Value to EBITDA Ratio|Protagonist (PTGX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Immunovant Inc|Enterprise Value to EBITDA Ratio KNSA|EV/EBITDA Multiple Grifols Biemat|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Adaptive Biotechnologies (ADPT)|celldex.com - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple AUPH (Aurinia Pharmaceuticals Inc.)|BioCryst Pharmaceuticals, Inc. (BCRX) - Company Value to EBITDA|Vera Pharma - EV/EBITDA Multiple|DNTH - EV/EBITDA Multiple|PHVS (Pharvaris N.V.) - Enterprise Value to EBITDA Ratio|ABCL: Enterprise Value to Operating Income Before Depreciation Ratio|TRML (Tourmaline Bio) - EV/EBITDA Multiple|EV/EBITDA Multiple Precigen Inc|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Pharming (PHAR)|NKTR (Nektar Corp) - Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple UPB (Upstream Bio Inc)|EV/EBITDA Multiple zenasbio.com ZBIO|IMNM: Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation GOSS (Gossamer Bio Inc)|KALV: EV/EBITDA Multiple|SEPN (Septerna Pharma) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|PVLA (Pieris Pharmaceuticals) - EV/EBITDA Multiple|savarapharma.com (SVRA) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Rigel Pharmaceuticals, Inc. (RIGL)|ANAB - Company Value to EBITDA|Astria Pharma - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio ENGN (enGene Corp)|RAPT Therapeutics - EV/EBITDA Multiple|Business Value to Operating Income Before Depreciation JBIO (Aerovate Therapeutics Inc)|ACRS: EV/EBITDA Multiple|Company Value to EBITDA Kyverna Therapeutics Inc. (KYTX)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Tiziana Life Sciences PLC|CABA: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple VTYX|EV/EBITDA Multiple theratech.com (THTX)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Avalo Therapeutics AVTX|ELDN (Eledon Pharmaceuticals Inc.) - Company Value to Operating Income Before Depreciation Ratio|Agenus Inc - EV/EBITDA Multiple|Company Value to EBITDA Climb Bio, Inc|ZURA (Zura Bio) - Enterprise Value to EBITDA Ratio|atyrpharma.com (ATYR) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio ADAG|IMA (Ikena Oncology, Inc.) - Enterprise Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple STTK|Total Company Value to Operating Income Before Depreciation Ratio equilliumbio.com|EV/EBITDA Multiple CNTB (Connect Biopharma Holdings Limited)|IMUX - Enterprise Value to EBITDA Ratio|IFRX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Total Company Value to Operating Income Before Depreciation Ratio X4 Pharmaceuticals Inc. XFOR|ACET: EV/EBITDA Multiple|Celularity (CELU) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio INMB|BRNS (barinthusbio.com) - Enterprise Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Kezar Life Sciences, Inc. (KZR)|SABS (SAB Biotherapeutics Inc.) - Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple AKTX (Akari Therapeutics plc)|EV/EBITDA Multiple Enlivex Therapeutics Ltd ENLV|QTTB - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio GOVX|EDSA: EV/EBITDA Multiple|iBio Inc - Business Value to Operating Income Before Depreciation|CARM (Carisma Therapeutics Inc) - EV/EBITDA Multiple|EV/EBITDA Multiple XTL Bio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Bolt Biotherapeutics (BOLT)|HCWB (hcwbiologics.com) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Aptevo Therapeutics Inc. APVO|AIM - Enterprise Value to EBITDA Ratio|Aditxt Corp - EV/EBITDA Multiple|GRI - EV/EBITDA Multiple|XRTX (XORTX Therapeutics Inc.) - Enterprise Value to EBITDA Ratio|reshapelifesciences.com - Business Value to Operating Income Before Depreciation|REVB (Revelation Biosciences, Inc.) - EV/EBITDA Multiple|Indaptus Therapeutics Inc (INDP) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Scinai (SCNI)|Enterprise Value to EBITDA Ratio calcimedica.com CALI|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Affimed N.V. AFMD|ALLK - Enterprise Value to EBITDA Ratio|HOOK: Enterprise Value to EBITDA Ratio|IGMS - EV/EBITDA Multiple|iTeos (ITOS) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation OCEA|TCBP (TC Biopharm) - EV/EBITDA Multiple|Company Value to EBITDA thirdharmonicbio.com THRD
